von Hippel-Lindau disease tumor suppressor

UniProtKB accession: P40337

Grouped By: Matching UniProtKB accession

Group Content:

Go to UniProtKB: P40337

UniProtKB description: Involved in the ubiquitination and subsequent proteasomal degradation via the von Hippel-Lindau ubiquitination complex. Seems to act as a target recruitment subunit in the E3 ubiquitin ligase complex and recruits hydroxylated hypoxia-inducible factor (HIF) under normoxic conditions. Involved in transcriptional repression through interaction with HIF1A, HIF1AN and histone deacetylases. Ubiquitinates, in an oxygen-responsive manner, ADRB2.

Group Members:

Release Date:

Experimental Features

Organisms

Protein Domains

Function

RCSB PDB is funded by the National Science Foundation (DBI-1832184), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.

Prepare Data

Validate Data

Deposit Data

Deposition Help & Resources

192489 Biological Macromolecular Structures Enabling Breakthroughs in Research and Education

von Hippel-Lindau disease tumor suppressor